膜结合的PI3Kα H1047R突变的结构和质效应以及药物发现的机会
Danai Maria Kotzampasi1,2, Zoe Cournia3
1Department of Biology, University of Crete, Heraklion, Greece. dkotzamp@bioacademy.gr.
Communications chemistry
|November 7, 2025
概括
在PI3Kα (酸胺3-酶α) 中的H1047R突变稳定了细胞膜上的蛋白质,增强了其活性. 这种突变促进了开放的形状,在蛋白质膜接口提供了新的治疗点.
科学领域:
- 生物化学和分子生物学
- 细胞信号传递 细胞信号传递
- 结构生物学 结构生物学
背景情况:
- 酸胺3-酶α (PI3Kα) 对于细胞生长和存活至关重要,通过PI3Kα/Akt路径起作用.
- PI3Kα作为外周膜蛋白,其激活发生在膜接口.
- 对于PI3Kα的精确活性构造以及瘤基因突变对其膜相互作用的影响仍然不太清楚.
研究的目的:
- 研究野生型 (WT) PI3Kα及其常见的致癌H1047R突变体的膜相互作用机制.
- 在膜结合的背景下阐明由H1047R突变引起的结构和动态变化.
- 在蛋白质膜接口上识别潜在的全囊,用于治疗向.
主要方法:
- 利用了全原子分子动力学 (MD) 模拟.
- 在模型膜上与HRAS复合模拟活体样PI3Kα WT和H1047R突变.
- 分析了蛋白质构造,基质协调,催化相互作用和全结合.
主要成果:
- 发现H1047R突变增强了基质协调和催化相互作用.
- H1047R诱导开放的C端形状,稳定PI3Kα与膜结合.
- 在C端和膜结合环2之间的联合被H1047R强化.
- 在膜上观察到WT和突变PI3Kα的不同形状集.
- 能够在蛋白质膜接口上基于结构预测全囊.
结论:
- H1047R突变通过特定的形状变化赋予PI3Kα增强的膜结合能力.
- 这些发现为在膜上的瘤性PI3Kα激活提供了机械的理解.
- 该研究强调蛋白质膜接口是针对PI3Kα驱动癌症的新疗法战略的潜在目标.
更多相关视频
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
9.2K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Protein Kinases and Phosphatases
14.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.9K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K
